Steven Zimmer, CEO of a start-up called MitoDys Therapeutics, and visiting researcher at the Structural Genomics Consortium talks to Enterprising Oxford about his career.
Read more (Enterprising Oxford website)
Innovation
8 July 2015
Steven Zimmer, CEO of a start-up called MitoDys Therapeutics, and visiting researcher at the Structural Genomics Consortium talks to Enterprising Oxford about his career.
Read more (Enterprising Oxford website)